NICE rejects use of Abiraterone for men with newly-diagnosed metastatic prostate cancer

Tackle is extremely disappointed to report the latest decision by the National Institute for Health and Care Excellence (NICE) to reject the use of Abiraterone for men with newly-diagnosed metastatic prostate cancer in England and Wales. Current first-line treatment for men with newly-diagnosed metastatic hormone sensitive prostate cancer (ndmhsPCa) is hormone therapy with additional chemotherapy (Docetaxel).  […]

Restarting Cancer Services in the NHS after COVID-19

Restarting Cancer Services in the NHS after COVID-19

COVID-19 is an unprecedented crisis which has had a profound impact on health and care services across the UK and will continue to have an impact for the months and years to come. To guide the restoration of services, Tackle Prostate Cancer along with 24 other cancer charities have come together – as One Cancer Voice – to develop […]

European Experts Back Prostate Cancer Screening

Tackle are at the forefront of the campaign for a targeted national screening programme for prostate cancer. Prostate cancer  is now the most commonly diagnosed cancer in UK and the annual toll of deaths from prostate cancer continues to rise, now topping 12,000, with deaths exceeding those from breast cancer. The European Association of Urology have now […]

Tackle Trustee Roshani Perera turns the spotlight on mental health in cancer care

An elderly couple hugging

Tackle Trustee Roshani Perera, director of the Wicked Minds healthcare consultancy, has written an article that has been published in PharmaTimes. The article looks at the provision of psychological support services for men living with prostate cancer and their carers and families across England based on a Tackle Freedom of Information request. Click here to read the article […]

European Experts Advocate Population-based Screening

Restarting Cancer Services in the NHS after COVID-19

Tackle wholeheartedly welcomes the news that the European Association of Urology, probably the most informed and expert major international body to make a judgement, has published a clear and unequivocal recommendation in favour of population-based Prostate Specific Antigen (PSA) screening to reduce the unacceptable death rate from Prostate Cancer (PCa). In a lengthy paper published […]

Tackle Makes Submission to UK National Screening Committee

In partnership with CHAPS and ORCHID, Tackle has submitted our views on prostate cancer screening to the UK National Screening Committee (NSC). In their last review in 2015/16, the NSC did not recommend screening for the following reasons: Evidence suggests prostate specific antigen (PSA) testing could reduce prostate-cancer related mortality by 21%. Despite this, the major harms of […]

Scottish Medicines Commission approves an extended use for Abiraterone

The Scottish Medicines Commission have recently approved the use of Abiraterone earlier in the treatment pathway for prostate cancer. This approval is specifically for patients with newly diagnosed, high risk, metastatic, hormone sensitive prostatic cancer.  Or to put it more simply, patients who have just been diagnosed with significant advanced disease who would normally just […]

Tackle awarded funding by the National Lottery

Tackle Prostate Cancer Small Grants Programme

Tackle Prostate Cancer, the voice of prostate cancer patients and their families in the UK have been awarded funding by the National Lottery for the project Tackling Prostate Cancer – peer-to-peer support for men with prostate cancer. The grant is for just under £238,000 over three years. There are three main aims for this project: to increase […]

Evaluating psychological support services available on the NHS

A support group

We are very pleased to announce that the results of our Freedom of Information request to all NHS Trusts in England and Wales have been published in BJUI International.  The background to this paper starts with Roger Wotton who believed strongly that the emotional and psychological aspects of prostate cancer can sometimes be more debilitating […]

Prostate Cancer Screening News

The MRI Scanning trial at UCLH highlighted in the national news brings hope of increased and improved prostate cancer screening for the UK’s number one male cancer causing 47,000 new cases and nearly 12,000 deaths each year. MRI scanning is now the best way to see if there is an aggressive, dangerous cancer inside the […]